Endogenous opioids inhibit the in vitro release of endogenous dopamine preferentially in the neural lobe of the rat neurointermediate lobe.
The release of endogenous dopamine (DA) from the in vitro incubated combined neurointermediate lobe (NIL) or isolated neural lobe (NL) was studied. In the presence of the DA uptake inhibitor GBR 12921 (200 nM), electrical stimulation of the pituitary stalk caused an increase of the outflow of DA from the NIL in a frequency-dependent manner. Naloxone (1 microM) enhanced the DA release from the NIL evoked by electrical stimulation at 7 or 15 Hz by about 40%, but had no effect on DA release evoked by stimulation at 3 Hz. When the electrical stimulation was carried out at 15 Hz, the evoked DA release (expressed as fraction of the DA tissue content) from the NL amounted to only 15% of that from the combined NIL. Naloxone (1 microM) increased the evoked DA release from the isolated NL by 242%. Thus, the effect of naloxone on DA release from the combined NIL may be confined mainly to the NL. In conclusion, DA release from the NL is under inhibitory control of endogenous opioids released from the NL during stimulation at 7 or 15 Hz. Beta-Endorphin, known to be released spontaneously at a high rate from in vitro incubated NILs, appears to lack inhibitory effects on DA release from the NIL.
Racké
K
K
Böhm
E
E
Hurth
S
S
Muscholl
E
E
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D004298:Dopamine / Q000378:metabolism*; D004558:Electric Stimulation; D004723:Endorphins / Q000502:physiology*; D005260:Female; D006719:Homovanillic Acid / Q000378:metabolism; D009270:Naloxone / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology*; D051381:Rats; D012636:Secretory Rate; D014667:Vasopressins / Q000378:metabolism
D004723:Endorphins; D015102:3,4-Dihydroxyphenylacetic Acid; D014667:Vasopressins; D009270:Naloxone; D004298:Dopamine; D006719:Homovanillic Acid